Get started
Author

Meredith B. Milstein

Observed names: M. Milstein, Meredith B Milstein, Meredith Milstein
OpenAlex ID: A5110097668
Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis
2014 · Silvia S Chiang, Faiz Ahmad Khan, et al. · The Lancet Infectious Diseases · 318
Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis
2017 · C. A. Peloquin, G. E. Velásquez, et al. · Antimicrobial Agents and Chemotherapy · 43
Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method
2016 · Carole D. Mitnick, Richard A. White, et al. · European Respiratory Journal · 35
PDF
Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial
2016 · Meredith Milstein, Leonid Lecca, et al. · BMC Infectious Diseases · 32
PDF
Bayesian adaptive randomization in a clinical trial to identify new regimens for MDR-TB: the endTB trial
2016 · M. Cellamare, M. Milstein, et al. · The International Journal of Tuberculosis and Lung Disease · 22
Estimating the global burden of multidrug-resistant tuberculosis among prevalent cases of tuberculosis
2016 · S. Nourzad, H. E. Jenkins, et al. · The International Journal of Tuberculosis and Lung Disease · 9
Treatment Outcomes for Adolescents With Multidrug-Resistant Tuberculosis in Lima, Peru
2016 · Dylan B. Tierney, Meredith B. Milstein, et al. · Global Pediatric Health · 8
PDF
(Re)moving the needle: prospects for all-oral treatment for multidrug-resistant tuberculosis
2016 · M. Milstein, A. Brzezinski, et al. · The International Journal of Tuberculosis and Lung Disease · 6
Erratum for Peloquin et al., “Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis”
2017 · C. A. Peloquin, G. E. Velásquez, et al. · Antimicrobial Agents and Chemotherapy · 2
Works count: 9
Citation count: 475
H-index: 7
I10-index: 5
Year
Topic
Type